A forum of leading hepatologists, endocrinologists and clinical development experts stewarding advances in science, clinical research and therapeutics for nonalcoholic fatty liver disease and steatohepatitis
4th Annual NASH Roundtable will be hosted at this year’s AASLD The Liver Meeting in Anaheim, California. Please contact firstname.lastname@example.org additional details.
Fact Sheet: NASH Roundtable, leading clinical development experts addressing challenges in NASH drug developmentView Fact Sheet »
MEMBER CO-AUTHORED PUBLICATIONS
Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes. Read More »
Defining comprehensive models of care for NAFLD. Read More »
Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis. Read More »
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease. Read More »